JP2002529520A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002529520A5 JP2002529520A5 JP2000582073A JP2000582073A JP2002529520A5 JP 2002529520 A5 JP2002529520 A5 JP 2002529520A5 JP 2000582073 A JP2000582073 A JP 2000582073A JP 2000582073 A JP2000582073 A JP 2000582073A JP 2002529520 A5 JP2002529520 A5 JP 2002529520A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- composition
- composition according
- isopropyl
- alkanoate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 6
- 229960004150 aciclovir Drugs 0.000 description 3
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 3
- 229960000890 hydrocortisone Drugs 0.000 description 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
- JNTOCHDNEULJHD-UHFFFAOYSA-N Penciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(CCC(CO)CO)C=N2 JNTOCHDNEULJHD-UHFFFAOYSA-N 0.000 description 2
- 229960001179 penciclovir Drugs 0.000 description 2
- SCBFBAWJWLXVHS-UHFFFAOYSA-N 2-amino-9-[4-hydroxy-2-(hydroxymethyl)butyl]-3h-purin-6-one Chemical compound N1C(N)=NC(=O)C2=C1N(CC(CO)CCO)C=N2 SCBFBAWJWLXVHS-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical group O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical class CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- -1 isopropyl ester Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 229940127073 nucleoside analogue Drugs 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9803929-0 | 1998-11-18 | ||
| SE9803929A SE9803929D0 (sv) | 1998-11-18 | 1998-11-18 | Antiviral formulation |
| PCT/SE1999/002043 WO2000029027A1 (en) | 1998-11-18 | 1999-11-12 | Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011087438A Division JP5420583B2 (ja) | 1998-11-18 | 2011-04-11 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002529520A JP2002529520A (ja) | 2002-09-10 |
| JP2002529520A5 true JP2002529520A5 (enExample) | 2006-11-30 |
Family
ID=20413320
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000582073A Pending JP2002529520A (ja) | 1998-11-18 | 1999-11-12 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
| JP2011087438A Expired - Lifetime JP5420583B2 (ja) | 1998-11-18 | 2011-04-11 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011087438A Expired - Lifetime JP5420583B2 (ja) | 1998-11-18 | 2011-04-11 | プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤 |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1131104B1 (enExample) |
| JP (2) | JP2002529520A (enExample) |
| KR (1) | KR100608963B1 (enExample) |
| CN (1) | CN1160128C (enExample) |
| AR (1) | AR023705A1 (enExample) |
| AT (1) | ATE288283T1 (enExample) |
| AU (1) | AU772435B2 (enExample) |
| CA (1) | CA2351463C (enExample) |
| DE (1) | DE69923584T2 (enExample) |
| DK (1) | DK1131104T3 (enExample) |
| EG (1) | EG23853A (enExample) |
| ES (1) | ES2233104T3 (enExample) |
| HK (1) | HK1042440B (enExample) |
| IL (2) | IL142702A0 (enExample) |
| MY (1) | MY122397A (enExample) |
| NZ (1) | NZ511832A (enExample) |
| PT (1) | PT1131104E (enExample) |
| SE (1) | SE9803929D0 (enExample) |
| TW (1) | TW589191B (enExample) |
| WO (1) | WO2000029027A1 (enExample) |
| ZA (1) | ZA200103335B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100956369B1 (ko) * | 2001-11-19 | 2010-05-10 | 메디진 아게 | 바이러스성 피부 질환 및 종양 질환 치료용 약제 |
| ZA200602544B (en) | 2003-10-09 | 2007-06-27 | Medigene Ag | The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| JP4972062B2 (ja) * | 2008-03-17 | 2012-07-11 | メディヴィル・アクチエボラーグ | 抗ウイルス製剤 |
| ES2955089T3 (es) * | 2018-08-17 | 2023-11-28 | Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi | Composición tópica estable en fase que comprende aciclovir e hidrocortisona |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW438585B (en) * | 1995-02-06 | 2001-06-07 | Astra Ab | Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections |
| US5760096A (en) * | 1996-10-18 | 1998-06-02 | Thornfeldt; Carl R. | Potent penetration enhancers |
-
1998
- 1998-11-18 SE SE9803929A patent/SE9803929D0/xx unknown
-
1999
- 1999-11-12 AU AU14364/00A patent/AU772435B2/en not_active Expired
- 1999-11-12 NZ NZ511832A patent/NZ511832A/en not_active IP Right Cessation
- 1999-11-12 EP EP99972109A patent/EP1131104B1/en not_active Expired - Lifetime
- 1999-11-12 DE DE69923584T patent/DE69923584T2/de not_active Expired - Lifetime
- 1999-11-12 HK HK02104279.2A patent/HK1042440B/zh not_active IP Right Cessation
- 1999-11-12 PT PT99972109T patent/PT1131104E/pt unknown
- 1999-11-12 CN CNB998133825A patent/CN1160128C/zh not_active Expired - Lifetime
- 1999-11-12 CA CA002351463A patent/CA2351463C/en not_active Expired - Lifetime
- 1999-11-12 ES ES99972109T patent/ES2233104T3/es not_active Expired - Lifetime
- 1999-11-12 JP JP2000582073A patent/JP2002529520A/ja active Pending
- 1999-11-12 IL IL14270299A patent/IL142702A0/xx active IP Right Grant
- 1999-11-12 KR KR1020017006232A patent/KR100608963B1/ko not_active Expired - Fee Related
- 1999-11-12 DK DK99972109T patent/DK1131104T3/da active
- 1999-11-12 AT AT99972109T patent/ATE288283T1/de active
- 1999-11-12 WO PCT/SE1999/002043 patent/WO2000029027A1/en not_active Ceased
- 1999-11-15 TW TW088119865A patent/TW589191B/zh not_active IP Right Cessation
- 1999-11-16 MY MYPI99004979A patent/MY122397A/en unknown
- 1999-11-16 EG EG146899A patent/EG23853A/xx active
- 1999-11-17 AR ARP990105846A patent/AR023705A1/es active IP Right Grant
-
2001
- 2001-04-19 IL IL142702A patent/IL142702A/en not_active IP Right Cessation
- 2001-04-24 ZA ZA200103335A patent/ZA200103335B/en unknown
-
2011
- 2011-04-11 JP JP2011087438A patent/JP5420583B2/ja not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002509074A5 (enExample) | ||
| ATE361093T1 (de) | Selektiv auf die leber wirkende pharmazeutisch aktive substanz | |
| KR900701817A (ko) | 뉴클레오사이드 유도체와 그의 제조방법 | |
| DE69932158D1 (de) | Pharmazeutische zusammenstellungen | |
| WO1996002244B1 (en) | A topical preparation for the prevention and treatment of lesions and sores associated with a herpes virus | |
| IE811617L (en) | Topical formulations of 9-(2-hydroxyethoxymethyl) guanine | |
| JPS6326120B2 (enExample) | ||
| GR3019984T3 (en) | An antivirally active pharmaceutical oil-in-water emulsion containing 9- (2-hydroxyethoxy)methyl]guanine (acyclovir) or a salt or ester thereof. | |
| JP2002529520A5 (enExample) | ||
| Shi et al. | Cardioprotective effects of morphine on rat heart suffering from ischemia and reperfusion | |
| JPS5592312A (en) | Suppository containing bronchodilating compound | |
| JP2009221186A5 (enExample) | ||
| McDonald | Cytotoxic agents for use in dermatology. I | |
| CN1312254A (zh) | 新的核苷 | |
| JPH10512549A (ja) | 可溶性の２−クロロ−２’−デオキシアデノシン配合物 | |
| EP0351215A3 (en) | Ester of 9-(2-hydroxyethoxymethyl) guanine | |
| NL300041I1 (nl) | Versterkingsmiddel voor het antineoplastisch effect en antineoplastisch middel. | |
| CA2152507A1 (en) | Novel combination of benzoquinazoline antifolates and protecting agents | |
| CA2414352A1 (en) | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies | |
| WO1990006671A2 (en) | Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections | |
| Nikkels et al. | Current treatments of muco-cutaneous herpes simplex virus infections | |
| AR023705A1 (es) | COMPOSICIoN ToPICA QUE COMPRENDE EL GLUCOCORTICOIDE ANTIINFLAMATORIO HIDROCORTISONA Y UN AGENTE ANTIVIRAL ANALOGO DE NUCLEOSIDO ACICLOVIR Y EL USO DE LA MISMA | |
| JPH02111726A (ja) | ヒト インターロイキン１を安定化する方法 | |
| IL56442A (en) | Solvent vehicle for the parenteral administration of therapeutics containing an adipic acid ester,pharmaceutical compositions comprising said vehicle and their use in the prophylaxis and/or treatment of certain diseases | |
| IT1254519B (it) | Associazioni di composti ad attivita' antivirale |